"
S(+)-Flurbiprofen Shows Potent PGE2 Inhibitory Activity in Inflammatory Cells, Superior Cell Transport Activity and Skin Permeability"
written by Yoshihisa Toda, Masanori Sugimoto, Hiromi Endo, Miho Kamezawa, Ichimaro Yamada, Shogo Kawabata, Shinsuke Kaku, Noboru Otsuka, Hideo Matsumoto,
published by
Pharmacology & Pharmacy,
Vol.7 No.8, 2016
has been cited by the following article(s):
[1]
|
Efficacy and safety of S‐flurbiprofen plaster in knee osteoarthritis patients: A 2‐week randomized controlled Phase III clinical trial compared to diclofenac gel
International Journal of Rheumatic Diseases,
2022
DOI:10.1111/1756-185X.14307
|
|
|
[2]
|
Analgesic effect of S (+)-flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E2
levels
Journal of Pharmacy and Pharmacology,
2018
DOI:10.1111/jphp.12914
|
|
|
[3]
|
Pharmacological action and clinical outcome of newly developed NSAIDs patch, “LOQOA® tape”
Folia Pharmacologica Japonica,
2018
DOI:10.1254/fpj.151.221
|
|
|
[4]
|
A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients
Clinical and Experimental Nephrology,
2017
DOI:10.1007/s10157-017-1406-9
|
|
|